
Erixone S 250mg/125mg Injection
Marketer
Erika Remedies
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Erixone S 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, this medication necessitates adherence to the prescribed schedule; prematurely halting treatment compromises efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention; allergic reactions (rash, pruritus, edema, dyspnea) require emergency care. Prior to commencing treatment, disclose all current medications and pre-existing conditions to your physician. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness necessitates abstention from driving. Ample rest, a nutritious diet, and sufficient hydration facilitate faster recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Erixone S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Erixone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Erixone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Erixone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Erixone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Erixone S 250mg/125mg Injection works:
The injectable formulation Erixone S, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-drug approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Erixone S 250mg/125mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Erixone S 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
The administration of Erixone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Erixone S 250mg/125mg Injection may induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Erixone S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The administration of Erixone S 250mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment. A modified dosage of Erixone S 250mg/125mg Injection might be necessary; physician consultation is advised. Dosage alteration for Erixone S 250mg/125mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Erixone S 250mg/125mg Injection :
Should you forget a scheduled dose of Erixone S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Erixone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
